Erin Wright
Stock Analyst at Morgan Stanley
(4.44)
# 339
Out of 5,044 analysts
238
Total ratings
64.12%
Success rate
13.39%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGN Align Technology | Maintains: Equal-Weight | $154 → $142 | $133.14 | +6.65% | 24 | Oct 21, 2025 | |
| OPCH Option Care Health | Initiates: Overweight | $35 | $28.20 | +24.11% | 1 | Oct 17, 2025 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $163 → $204 | $162.84 | +25.28% | 3 | Oct 14, 2025 | |
| ELV Elevance Health | Maintains: Equal-Weight | $316 → $359 | $339.40 | +5.77% | 4 | Oct 14, 2025 | |
| CVS CVS Health | Maintains: Overweight | $82 → $89 | $82.20 | +8.27% | 6 | Oct 14, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $25 → $32 | $34.00 | -5.88% | 4 | Oct 14, 2025 | |
| PSX Phillips 66 | Maintains: Equal-Weight | $128 → $140 | $133.66 | +4.74% | 2 | Oct 3, 2025 | |
| MCK McKesson | Maintains: Overweight | $810 → $857 | $804.59 | +6.51% | 9 | Sep 24, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $722 → $765 | $634.36 | +20.59% | 18 | Aug 15, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $16 → $17 | $20.06 | -15.25% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $290 → $277 | $294.80 | -6.04% | 4 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $313 → $330 | $335.64 | -1.68% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $181 → $190 | $162.79 | +16.71% | 12 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $41.68 | -37.62% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $308.41 | +26.46% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $2.57 | +24.51% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $13 | $22.12 | -41.23% | 11 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $243 → $238 | $145.41 | +63.68% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $13.07 | +75.98% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $178.28 | -3.52% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $69 → $65 | $63.21 | +2.83% | 4 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $367.84 | +59.58% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $259.69 | +15.52% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $15.08 | +178.51% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $216.90 | +32.78% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $187.93 | +87.30% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.23 | +1,262.23% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $580.53 | -68.82% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $57.33 | -70.35% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $34.16 | +254.22% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $557.63 | +4.01% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $12.13 | +188.54% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $177.73 | +15.34% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $23.43 | -53.05% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $218.13 | -28.02% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $38 | $28.18 | +34.85% | 1 | May 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $5.28 | +221.97% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $485.77 | -36.60% | 1 | Oct 25, 2017 |
Align Technology
Oct 21, 2025
Maintains: Equal-Weight
Price Target: $154 → $142
Current: $133.14
Upside: +6.65%
Option Care Health
Oct 17, 2025
Initiates: Overweight
Price Target: $35
Current: $28.20
Upside: +24.11%
Molina Healthcare
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $162.84
Upside: +25.28%
Elevance Health
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $316 → $359
Current: $339.40
Upside: +5.77%
CVS Health
Oct 14, 2025
Maintains: Overweight
Price Target: $82 → $89
Current: $82.20
Upside: +8.27%
BrightSpring Health Services
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $34.00
Upside: -5.88%
Phillips 66
Oct 3, 2025
Maintains: Equal-Weight
Price Target: $128 → $140
Current: $133.66
Upside: +4.74%
McKesson
Sep 24, 2025
Maintains: Overweight
Price Target: $810 → $857
Current: $804.59
Upside: +6.51%
IDEXX Laboratories
Aug 15, 2025
Maintains: Overweight
Price Target: $722 → $765
Current: $634.36
Upside: +20.59%
Envista Holdings
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $20.06
Upside: -15.25%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $290 → $277
Current: $294.80
Upside: -6.04%
Jul 16, 2025
Maintains: Equal-Weight
Price Target: $313 → $330
Current: $335.64
Upside: -1.68%
Jul 16, 2025
Maintains: Overweight
Price Target: $181 → $190
Current: $162.79
Upside: +16.71%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $41.68
Upside: -37.62%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $308.41
Upside: +26.46%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $2.57
Upside: +24.51%
Feb 26, 2025
Maintains: Equal-Weight
Price Target: $14 → $13
Current: $22.12
Upside: -41.23%
Feb 14, 2025
Maintains: Overweight
Price Target: $243 → $238
Current: $145.41
Upside: +63.68%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $13.07
Upside: +75.98%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $178.28
Upside: -3.52%
Nov 14, 2023
Maintains: Underweight
Price Target: $69 → $65
Current: $63.21
Upside: +2.83%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $367.84
Upside: +59.58%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $259.69
Upside: +15.52%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $15.08
Upside: +178.51%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $216.90
Upside: +32.78%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $187.93
Upside: +87.30%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.23
Upside: +1,262.23%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $580.53
Upside: -68.82%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $57.33
Upside: -70.35%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $34.16
Upside: +254.22%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $557.63
Upside: +4.01%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $12.13
Upside: +188.54%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $177.73
Upside: +15.34%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $23.43
Upside: -53.05%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $218.13
Upside: -28.02%
May 9, 2018
Maintains: Outperform
Price Target: $42 → $38
Current: $28.18
Upside: +34.85%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $5.28
Upside: +221.97%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $485.77
Upside: -36.60%